OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)
ACCESS
1 other identifier
interventional
100
1 country
1
Brief Summary
The significance of the Post-COVID Syndrome (PCS) has been widely acknowledged. Various efforts are made to find out about the pathomechanisms behind PCS and to establish therapies. One sub-group of PCS-patients, however, is generally excluded from any studies, and that are those who are unable to visit outpatient clinics or hospitals for diagnostic work up or participation in clinical trials, as they are unable to leave their home and to seek medical support on their own physical and mental capabilities. They are housebound, mostly or totally bedridden. Similar cases are known from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) of any cause and are graded as moderate to very severe ME/CFS according to the Canadian Consensus criteria. The patients are usually seen by their family doctor and have no access to medical specialists. The planned project aims to find out about the prevalence of this most severe manifestation of PCS, the clinical characteristics, the prevalence of mimics, risk factors and impact of the disease on the patients' life and their family/caregivers. Individual care and treatment plans will be developed and the effect of monthly consultation hours for patients and caregivers upon the patients' health status and the caregiver burden will be evaluated in a randomized controlled trial. The project will be performed in close cooperation between patients, caregivers, the patient's family doctor and a board of experts from internal medicine, neurology, psychosomatic medicine and general medicine at Hannover Medical School. We expect an improvement of the patients' and caregivers wellbeing with intensified medical care. We are aware, however, that intensification of the patient-doctor interaction carries the risk to exacerbate the patients' symptoms. The results of our study will show how current models of care for PCS and ME/CFS patients should be modified to fit to the individual patient's aims and capacities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
January 11, 2026
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
January 21, 2026
January 1, 2026
2.8 years
January 11, 2026
January 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Short Form (SF)-36 health survey, physical score
Short-Form (SF-36) health survey to assess health related quality of life, here the physical score. Higher values indicate better health status. The range depends on age, gender and education.
1 year
Study Arms (2)
intensified medical care
EXPERIMENTALmonthly online visit in addition to standard care
standard care
ACTIVE COMPARATORstandard care as decided after discussion between family doctor and visiting specialists
Interventions
Eligibility Criteria
You may qualify if:
- ME/CFS according to the Canadian Consensus Criteria
- Bell Score ≤ 30
- Duration of the postexertional malaise (PEM) \> 14 hours
- Age \> 18 years and \< 70
You may not qualify if:
- \- Pre-existing conditions or comorbidities that have (or could have) led to a restriction of mobility or mental capacity, such as various diseases of the central nervous system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hannover Medical School
Hanover, 30625, Germany
Related Publications (5)
Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available.
PMID: 7203086RESULTBraun M, Scholz U, Hornung R, Martin M. The burden of spousal caregiving: a preliminary psychometric evaluation of the German version of the Zarit burden interview. Aging Ment Health. 2010 Mar;14(2):159-67. doi: 10.1080/13607860802459781.
PMID: 20336547RESULTMorfeld M, Kirchberger I, Bullinger M. SF-36- Fragebogen zum Gesundheitszustand, 2. Auflage, Hogrefe Verlag, 2011
RESULTSommerfelt K, Schei T, Angelsen A. Severe and Very Severe Myalgic Encephalopathy/Chronic Fatigue Syndrome ME/CFS in Norway: Symptom Burden and Access to Care. J Clin Med. 2023 Feb 13;12(4):1487. doi: 10.3390/jcm12041487.
PMID: 36836022RESULTKeith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18. No abstract available.
PMID: 3503663RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meike Dirks, MD
Hannover Medical School
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant, Department of Neurology, Principal Investigator
Study Record Dates
First Submitted
January 11, 2026
First Posted
January 20, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The IPD and supporting information will be available after final data analysis for ACCESS for at least 10 years
- Access Criteria
- Anonymous data will be available for scientific purposes after reasonable request
It is planned to share the data with the registry of the outpatient clinic for rare diseases at MHH